Progesterone, brain-derived neurotrophic factor and neuroprotection

Neuroscience

Volumn 239, Issue , 2013, Pages 84-91

  Singh, M ^a   Su, C ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

BDNF; Brain; MPA; Neuroprotection; Progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN; GESTAGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH FACTOR; MEDROXYPROGESTERONE ACETATE; NEUROTROPHIN; PLACEBO; PROGESTERONE;

AFFECT; ALZHEIMER DISEASE; BRAIN DYSFUNCTION; BRAIN EDEMA; BRAIN INFARCTION; BRAIN LEVEL; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; COGNITION; DRUG ANTAGONISM; DRUG EFFICACY; HORMONE ACTION; HUMAN; LIPID PEROXIDATION; LONG TERM POTENTIATION; MEDIATOR; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; REPRODUCTION; REVIEW; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; NEUROPROTECTIVE AGENTS; PROGESTERONE;

EID: 84876079860     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.056     Document Type: Review

References (103)

1. Aguirre C., Jayaraman A., Pike C., Baudry M. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta. J Neurochem 2010, 115:1277-1287.
2. Aguirre C.C., Baudry M. Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci 2009, 29:447-454.
3. Ardeshiri A., Kelley M.H., Korner I.P., Hurn P.D., Herson P.S. Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivation. Eur J Neurosci 2006, 24:2567-2574.
4. Bejot Y., Prigent-Tessier A., Cachia C., Giroud M., Mossiat C., Bertrand N., Garnier P., Marie C. Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem Int 2011, 58:102-111.
5. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
6. Carroll J.C., Rosario E.R., Pike C.J. Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats. Neurosci Lett 2008, 445:229-232.
7. Causing C.G., Gloster A., Aloyz R., Bamji S.X., Chang E., Fawcett J., Kuchel G., Miller F.D. Synaptic innervation density is regulated by neuron-derived BDNF. Neuron 1997, 18:257-267.
8. Cekic M., Johnson S.J., Bhatt V.H., Stein D.G. Progesterone treatment alters neurotrophin/proneurotrophin balance and receptor expression in rats with traumatic brain injury. Restor Neurol Neurosci 2012, 30:115-126.
9. Chen J., Chopp M., Li Y. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 1999, 171:24-30.
10. Chen J., Zacharek A., Zhang C., Jiang H., Li Y., Roberts C., Lu M., Kapke A., Chopp M. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 2005, 25:2366-2375.
11. Chen L., Miyamoto Y., Furuya K., Dai X.N., Mori N., Sokabe M. Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling. Neuropharmacology 2006, 51:659-670.
12. Ciriza I., Azcoitia I., Garcia-Segura L.M. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J Neuroendocrinol 2004, 16:58-63.
13. Cohen S., Greenberg M.E. Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu Rev Cell Dev Biol 2008, 24:183-209.
14. Connor B., Young D., Yan Q., Faull R.L., Synek B., Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997, 49:71-81.
15. Crozier R.A., Black I.B., Plummer M.R. Blockade of NR2B-containing NMDA receptors prevents BDNF enhancement of glutamatergic transmission in hippocampal neurons. Learn Mem 1999, 6:257-266.
16. Deutsch S.I., Mastropaolo J., Hitri A. GABA-active steroids: endogenous modulators of GABA-gated chloride ion conductance. Clin Neuropharmacol 1992, 15:352-364.
17. Djebaili M., Hoffman S.W., Stein D.G. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 2004, 123:349-359.
18. Fahnestock M., Michalski B., Xu B., Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001, 18:210-220.
19. Falkenstein E., Schmieding K., Lange A., Meyer C., Gerdes D., Welsch U., Wehling M. Localization of a putative progesterone membrane binding protein in porcine hepatocytes. Cell Mol Biol (Noisy-le-grand) 1998, 44:571-578.
20. Ferrer I., Marin C., Rey M.J., Ribalta T., Goutan E., Blanco R., Tolosa E., Marti E. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 1999, 58:729-739.
21. Foy M.R., Akopian G., Thompson R.F. Progesterone regulation of synaptic transmission and plasticity in rodent hippocampus. Learn Mem 2008, 15:820-822.
22. Gambrell R.D. The role of hormones in the etiology and prevention of endometrial cancer. Clin Obstet Gynaecol 1986, 13:695-723.
23. Gao X., Chen J. Conditional knockout of brain-derived neurotrophic factor in the hippocampus increases death of adult-born immature neurons following traumatic brain injury. J Neurotrauma 2009, 26:1325-1335.
24. Gonzalez Deniselle M.C., Garay L., Gonzalez S., Saravia F., Labombarda F., Guennoun R., Schumacher M., De Nicola A.F. Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons. Exp Neurol 2007, 203:406-414.
25. Gonzalez Deniselle M.C., Lopez Costa J.J., Gonzalez S.L., Labombarda F., Garay L., Guennoun R., Schumacher M., De Nicola A.F. Basis of progesterone protection in spinal cord neurodegeneration. J Steroid Biochem Mol Biol 2002, 83:199-209.
26. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., De Nicola A.F. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis 2002, 11:457-468.
27. Gonzalez S.L., Labombarda F., Gonzalez Deniselle M.C., Guennoun R., Schumacher M., De Nicola A.F. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 2004, 125:605-614.
28. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996, 66:1836-1844.
29. Griesbach G.S., Hovda D.A., Molteni R., Wu A., Gomez-Pinilla F. Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 2004, 125:129-139.
30. Han B.H., Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781.
31. He J., Evans C.O., Hoffman S.W., Oyesiku N.M., Stein D.G. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004, 189:404-412.
32. He J., Hoffman S.W., Stein D.G. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci 2004, 22:19-31.
33. Hetman M., Kanning K., Cavanaugh J.E., Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular-signal regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 1999, 274:22569-22580.
34. Hirvonen E. Progestins. Maturitas 1996, 23(Suppl.):S13-18.
35. Hock C., Heese K., Muller-Spahn F., Hulette C., Rosenberg C., Otten U. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 1998, 241:151-154.
36. Ibanez C., Shields S.A., El-Etr M., Leonelli E., Magnaghi V., Li W.W., Sim F.J., Baulieu E.E., Melcangi R.C., Schumacher M., Franklin R.J. Steroids and the reversal of age-associated changes in myelination and remyelination. Prog Neurobiol 2003, 71:49-56.
37. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 2012, 210:442-450.
38. Jayaraman A., Pike C.J. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol 2009, 21:77-81.
39. Jiang N., Chopp M., Stein D., Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 1996, 735:101-107.
40. Jodhka P.K., Kaur P., Underwood W., Lydon J.P., Singh M. The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression. Endocrinology 2009, 150:3162-3168.
41. Junpeng M, Huang S, Qin S (2011) Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev CD008409.
42. Kaplan G.B., Vasterling J.J., Vedak P.C. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behavioural pharmacology 2010, 21:427-437.
43. Kaur P., Jodhka P.K., Underwood W.A., Bowles C.A., de Fiebre N.C., de Fiebre C.M., Singh M. Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res 2007, 85:2441-2449.
44. Ke F.C., Ramirez V.D. Binding of progesterone to nerve cell membranes of rat brain using progesterone conjugated to 125I-bovine serum albumin as a ligand. J Neurochem 1990, 54:467-472.
45. Krebs C.J., Jarvis E.D., Chan J., Lydon J.P., Ogawa S., Pfaff D.W. A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors. Proc Natl Acad Sci U S A 2000, 97:12816-12821.
46. Kumon Y., Kim S.C., Tompkins P., Stevens A., Sakaki S., Loftus C.M. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg 2000, 92:848-852.
47. Lazarovici P., Cohen G., Arien-Zakay H., Chen J., Zhang C., Chopp M., Jiang H. Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models. J Mol Neurosci 2012, [E-pub ahead of print].
48. Levine E.S., Kolb J.E. Brain-derived neurotrophic factor increases activity of NR2B-containing N-methyl-d-aspartate receptors in excised patches from hippocampal neurons. J Neurosci Res 2000, 62:357-362.
49. Lin S.Y., Wu K., Levine E.S., Mount H.T., Suen P.C., Black I.B. BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res Mol Brain Res 1998, 55:20-27.
50. Lorenz L., Dang J., Misiak M., Tameh Abolfazl A., Beyer C., Kipp M. Combined 17beta-oestradiol and progesterone treatment prevents neuronal cell injury in cortical but not midbrain neurones or neuroblastoma cells. J Neuroendocrinol 2009, 21:841-849.
51. Lu B., Pang P.T., Woo N.H. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005, 6:603-614.
52. Lu Y., Christian K., Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol Learn Mem 2008, 89:312-323.
53. Mannella P., Sanchez A.M., Giretti M.S., Genazzani A.R., Simoncini T. Oestrogen and progestins differently prevent glutamate toxicity in cortical neurons depending on prior hormonal exposure via the induction of neural nitric oxide synthase. Steroids 2009, 74:650-656.
54. Matsumoto T., Rauskolb S., Polack M., Klose J., Kolbeck R., Korte M., Barde Y.A. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosci 2008, 11:131-133.
55. McEwen B.S., Woolley C.S. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994, 29:431-436.
56. Meyer C., Schmid R., Scriba P.C., Wehling M. Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem 1996, 239:726-731.
57. Min L., Takemori H., Nonaka Y., Katoh Y., Doi J., Horike N., Osamu H., Raza F.S., Vinson G.P., Okamoto M. Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis. Mol Cell Endocrinol 2004, 215:143-148.
58. Minichiello L. TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 2009, 10:850-860.
59. Miyagawa K., Vidgoff J., Hermsmeyer K. Ca2+ release mechanism of primate drug-induced coronary vasospasm. Am J Physiol 1997, 272:H2645-H2654.
60. Morali G., Letechipia-Vallejo G., Lopez-Loeza E., Montes P., Hernandez-Morales L., Cervantes M. Post-ischemic administration of progesterone in rats exerts neuroprotective effects on the hippocampus. Neurosci Lett 2005, 382:286-290.
61. Murer M.G., Yan Q., Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001, 63:71-124.
62. Murphy D.D., Segal M. Progesterone prevents estradiol-induced dendritic spine formation in cultured hippocampal neurons. Neuroendocrinology 2000, 72:133-143.
63. Nguyen P.V., Kandel E.R. A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices. J Neurosci 1996, 16:3189-3198.
64. Nilsen J., Brinton R.D. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport 2002, 13:825-830.
65. Nilsen J., Brinton R.D. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002, 143:205-212.
66. Nilsen J., Brinton R.D. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci U S A 2003, 100:10506-10511.
67. Nin M.S., Martinez L.A., Pibiri F., Nelson M., Pinna G. Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression. Front Endocrinol 2011, 2:73.
68. Pettus E.H., Wright D.W., Stein D.G., Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005, 1049:112-119.
69. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991, 7:695-702.
70. Ploughman M., Windle V., MacLellan C.L., White N., Dore J.J., Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 2009, 40:1490-1495.
71. Pruginin-Bluger M., Shelton D.L., Kalcheim C. A paracrine effect for neuron-derived BDNF in development of dorsal root ganglia: stimulation of Schwann cell myelin protein expression by glial cells. Mech Dev 1997, 61:99-111.
72. Roof R.L., Duvdevani R., Braswell L., Stein D.G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994, 129:64-69.
73. Roof R.L., Hall E.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000, 17:367-388.
74. Rosano G.M., Webb C.M., Chierchia S., Morgani G.L., Gabraele M., Sarrel P.M., de Ziegler D., Collins P. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J Am Coll Cardiol 2000, 36:2154-2159.
75. Rosario E.R., Ramsden M., Pike C.J. Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res 2006, 1099:206-210.
76. Sakamoto H., Ukena K., Takemori H., Okamoto M., Kawata M., Tsutsui K. Expression and localization of 25-Dx, a membrane-associated putative progesterone-binding protein, in the developing Purkinje cell. Neuroscience 2004, 126:325-334.
77. Sayeed I., Parvez S., Wali B., Siemen D., Stein D.G. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res 2009, 1263:165-173.
78. Schuman E.M. Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 1999, 9:105-109.
79. Singh M. Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 2001, 14:407-415.
80. Singh M., Meyer E.M., Simpkins J.W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995, 136:2320-2324.
81. Strauss J., Barbieri R. Yen and Jaffe's reproductive endocrinology 2004, Saunders.
82. Su C., Cunningham R.L., Rybalchenko N., Singh M. Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (pgrmc1)-dependent ERK5 signaling. Endocrinology 2012, 153:4389-4400.
83. Suen P.C., Wu K., Levine E.S., Mount H.T., Xu J.L., Lin S.Y., Black I.B. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-d-aspartate receptor subunit 1. Proc Natl Acad Sci U S A 1997, 94:8191-8195.
84. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 2008, 59:201-220.
85. Thomas A.J., Nockels R.P., Pan H.Q., Shaffrey C.I., Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 1999, 24:2134-2138.
86. Towle A.C., Sze P.Y. Steroid binding to synaptic plasma membrane: differential binding of glucocorticoids and gonadal steroids. J Steroid Biochem 1983, 18:135-143.
87. Vandromme M., Melton S.M., Kerby J.D. Progesterone in traumatic brain injury: time to move on to phase III trials. Crit Care 2008, 12:153.
88. Vitarbo E.A., Chatzipanteli K., Kinoshita K., Truettner J.S., Alonso O.F., Dietrich W.D. Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 2004, 55:416-424.
89. Wali B., Sayeed I., Stein D.G. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci 2011, 29:61-71.
90. Wang J.M., Liu L., Irwin R.W., Chen S., Brinton R.D. Regenerative potential of allopregnanolone. Brain Res Rev 2008, 57:398-409.
91. Woolley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993, 336:293-306.
92. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007, 49:391-402. 402 e391-e392.
93. Wu H., Lu D., Jiang H., Xiong Y., Qu C., Li B., Mahmood A., Zhou D., Chopp M. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 2008, 25:130-139.
94. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008, 12:R61.
95. Xu F., Plummer M.R., Len G.W., Nakazawa T., Yamamoto T., Black I.B., Wu K. Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation. Brain Res 2006, 1121:22-34.
96. Yao J., Chen S., Cadenas E., Brinton R.D. Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone. Brain Res 2011, 1379:2-10.
97. Ying S.W., Futter M., Rosenblum K., Webber M.J., Hunt S.P., Bliss T.V., Bramham C.R. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 2002, 22:1532-1540.
98. Yoshii A., Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 2010, 70:304-322.
99. Zhang J., Yu Z., Yu Z., Yang Z., Zhao H., Liu L., Zhao J. RAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int J Clin Exp Pathol 2011, 4:496-504.
100. Zhao Y., Wang J., Liu C., Jiang C., Zhao C., Zhu Z. Progesterone influences postischemic synaptogenesis in the CA1 region of the hippocampus in rats. Synapse 2011, 65:880-891.
101. Zhu Y., Bond J., Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A 2003, 100:2237-2242.
102. Zhu Y., Rice C.D., Pang Y., Pace M., Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci U S A 2003, 100:2231-2236.
103. Zuccato C., Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 2009, 5:311-322.